Introduction: With the advent of the COVID-19 pandemic, numerous questions have arisen regarding the screening, diagnosis, treatment, and prognosis of infected patients. Among these, screening infected patients through body temperature measurement has proven ineffective. However, doubts persist regarding the role of fever as a prognostic factor in the disease.
View Article and Find Full Text PDFObjective: This study aimed to compare the smile attractiveness after non-extraction treatment with self-ligating and rapid maxillary expansion (RME), to compare it to a control group treat with conventional fixed appliances and to evaluate the influence of buccal and posterior corridor areas in smile aesthetics.
Settings And Sample Population: The sample consisted of frontal posed smile photographs of patients treated with self-ligating and conventional appliances with and without RME.
Material And Methods: G1-treated with Damon self-ligating system (n = 20), G2-treated with RME and conventional fixed appliances (n = 22) and G3-treated only with conventional fixed appliances (n = 20).
Diarrhea is a condition in which the individual has about three or more daily bowel movements, followed by changes in stool consistency. It is currently considered as one of the worst public health problems due to the number of cases and deaths involved and difficulty of treatment. Thus, the use of natural products is an alternative for new treatments.
View Article and Find Full Text PDFBackground: The objective of this work is to test the null hypothesis that there is no difference in the torque expression among different esthetic brackets.
Material And Methods: Five ceramic self-ligating brackets (In-Ovation C - GAC, Damon Clear-Ormco, QuicKlear-Forestadent, Click-It -TP Orthodontics, Clarity SL-3M Unitek) and 4 ceramic conventional brackets (Inspire Ice-Ormco, InVu Ceramic-TP Orthodontics, Ceramic Roth-Morelli, Clarity Metal-Reinforced Ceramic Bracket-3M Unitek) were selected. Metallic Damon MX self-ligating bracket (Ormco) was used as control.
Introduction: In acute myocardial infarction (AMI), each 18 mg/dl (1 mmol/L) increment is associated with a 3% increase in mortality rates. All strategies applied for reducing blood glucose to this date, however, have not presented encouraging results.
Methodology: We searched the Medline (PubMed) and Cochrane Library databases for randomized clinical trials (RCTs) from 1995 to 2017 that used the intensive strategy or GIK therapy for blood glucose control during the acute stage of the AMI.